GeneTex

  • Country / Location Selection

United States (US)

IKK epsilon peptide

Cat. No. GTX27897

Application

 Neutralizing/Inhibition

Species

 Human
Package
50 μg ($139)
See all IKK epsilon products

APPLICATION

Application Note

The peptide is used for blocking the antibody activity of IKKe/IKK-I (GTX27891). Itusually blocks the antibody activity completely in Western blot by incubating the peptide withequal volume of antibody for 30 min at 37ºC

PROPERTIES

Form

Liquid

Buffer

PBS, 0.1% BSA

Preservative

0.02% Sodium azide

Storage

Store the peptide at -20ºC, stable for one year.

Concentration

0.20 mg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.

TARGET

Synonyms

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Epsilon , Ikk-E , Ikk-I , Ikke , Ikki , Ikbke

Background

IKBKE is a noncanonical I-kappa-B (see MIM 164008) kinase (IKK) that is essential for regulating antiviral signaling pathways. IKBKE has also been identified as a breast cancer (MIM 114480) oncogene and is amplified and overexpressed in over 30% of breast carcinomas and breast cancer cell lines (Hutti et al., 2009 [PubMed 19481526]).[supplied by OMIM]

Research Area

REFERENCE

There are currently no references for IKK epsilon peptide (GTX27897). Be the first to share your publications with this product.
Submit a Reference

REVIEW

There are currently no reviews for IKK epsilon peptide (GTX27897). Be the first to share your experience with this product.
Submit a Review
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139